Future Medicine Co., Ltd. (XKON: 341170)
South Korea
· Delayed Price · Currency is KRW
1,900.00
0.00 (0.00%)
At close: Sep 10, 2024
Future Medicine Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
TTM
| FY 2021 | FY 2020 | FY 2019 |
Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -13,367 | -13,001 | -10,502 | -10,702 |
Depreciation & Amortization | 447.28 | 428.34 | 322.39 | 290.92 |
Loss (Gain) From Sale of Assets | 1.42 | 1.42 | - | 15.64 |
Asset Writedown & Restructuring Costs | - | - | - | 30 |
Stock-Based Compensation | 455.33 | 437.1 | 256.07 | 114.48 |
Provision & Write-off of Bad Debts | - | - | -0.15 | 0.15 |
Other Operating Activities | 6,714 | 6,704 | 4,762 | 3,631 |
Change in Accounts Receivable | - | - | 15 | 7 |
Change in Accounts Payable | - | - | - | -8.57 |
Change in Unearned Revenue | - | - | -51.46 | 21.47 |
Change in Other Net Operating Assets | -1,346 | -1,117 | 985.36 | 36.43 |
Operating Cash Flow | -7,094 | -6,547 | -4,213 | -6,563 |
Capital Expenditures | -110.72 | -139.76 | -86.9 | -482.31 |
Sale (Purchase) of Intangibles | -100 | -400 | -231.01 | -2.6 |
Investment in Securities | 6,598 | -53.5 | -3,000 | 2,957 |
Other Investing Activities | - | - | - | 33.75 |
Investing Cash Flow | 6,388 | -593.26 | -3,318 | 2,506 |
Long-Term Debt Issued | - | - | - | 7,040 |
Short-Term Debt Repaid | - | - | - | -202 |
Long-Term Debt Repaid | - | -148.6 | -131.21 | -130.74 |
Total Debt Repaid | -186.01 | -148.6 | -131.21 | -332.74 |
Net Debt Issued (Repaid) | -186.01 | -148.6 | -131.21 | 6,707 |
Issuance of Common Stock | - | - | 2,270 | - |
Other Financing Activities | 0 | 0 | - | - |
Financing Cash Flow | -186.01 | 5,890 | 8,839 | 6,707 |
Foreign Exchange Rate Adjustments | 36.07 | -0.45 | -0.11 | -0.02 |
Net Cash Flow | -856.58 | -1,251 | 1,307 | 2,650 |
Free Cash Flow | -7,205 | -6,686 | -4,300 | -7,046 |
Free Cash Flow Margin | -720.50% | -668.64% | - | - |
Free Cash Flow Per Share | -882.61 | -885.51 | -664.32 | -1161.34 |
Cash Interest Paid | 16.22 | 12.67 | 25 | 4.29 |
Cash Income Tax Paid | - | - | - | 10.39 |
Levered Free Cash Flow | - | -19,496 | 4,540 | - |
Unlevered Free Cash Flow | - | -18,524 | 5,551 | - |
Change in Net Working Capital | - | 14,471 | -9,061 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.